| Name | Title | Contact Details |
|---|
We re committed to breakthrough firsts in womens sexual health. Novel ideas fuel our entrepreneurial passion. At Sprout, we celebrate ownership, boldness, quirkiness, learning, family and appreciation. They are central to what we stand for and what we re trying to collectively accomplish.
Sentage Corporation is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At PreferredOne, our name says it all. You, our valued members, are our preferred ones. Everything we do is for one purpose - to make your experience the best it can be. We offer individual health insurance, family medical plans and group health insurance to fit your needs and budget, plus wellness programs to help you stay healthy. We are known for outstanding customer service and for paying claims promptly, and our representatives are available to answer any questions you have about health care coverage. PreferredOne has served our Minnesota and upper Midwest members for almost 30 years.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Celestiallabs Inc. is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.